Yale University

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

TitlePrognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.
Publication TypeJournal Article
Year of Publication2002
AuthorsEgger, Matthias, Margaret May, Geneviève Chêne, Andrew N. Phillips, Bruno Ledergerber, François Dabis, Dominique Costagliola, Antonella d'Arminio Monforte, Frank de Wolf, Peter Reiss, Jens D. Lundgren, Amy C. Justice, Schlomo Staszewski, Catherine Leport, Robert S. Hogg, Caroline A. Sabin, John M. Gill, Bernd Salzberger, and Jonathan A. C. Sterne
Corporate AuthorsART Cohort Collaboration
JournalLancet
Volume360
Issue9327
Pagination119-29
Date Published2002 Jul 13
ISSN0140-6736
KeywordsAdolescent, Adult, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, Europe, Female, HIV Infections, HIV-1, Humans, Male, Middle Aged, Prognosis, Prospective Studies, Risk Factors, Survival Analysis, United States, Viral Load
AbstractInsufficient data are available from single cohort studies to allow estimation of the prognosis of HIV-1 infected, treatment-naive patients who start highly active antiretroviral therapy (HAART). The ART Cohort Collaboration, which includes 13 cohort studies from Europe and North America, was established to fill this knowledge gap.
DOI10.1016/S0140-6736(02)09411-4
Alternate JournalLancet

External Links